D57.431
Sickle-cell thalassemia beta zero with acute chest syndrome
Clinical Classification Guidelines
Inclusion Terms
- HbS-beta zero with acute chest syndrome
- Sickle-cell beta zero with acute chest syndrome
Medical Intelligence & Overview
Sickle-cell thalassemia beta zero with acute chest syndrome is a complex blood disorder characterized by abnormal hemoglobin production, leading to distorted, sickle-shaped red blood cells. This condition combines features of sickle-cell disease and beta-thalassemia, resulting in severe health complications. An acute chest syndrome is a life-threatening complication often seen in affected individuals, marked by respiratory distress and chest pain. Recognizing this condition is crucial for prompt medical intervention and management.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting hemoglobin production Inheritance of sickle-cell anemia and beta-thalassemia mutations from parents Formation of abnormal hemoglobin, HbS, leading to sickled red blood cells Absence or reduction of beta-globin chains (beta zero mutation), worsening blood cell deformities Environmental stressors like infections or dehydration that trigger acute episodes
Key Symptoms: Chest pain or pressure Shortness of breath or rapid breathing Fever and chills Cough, possibly with blood-streaked sputum Jaundice (yellowing of the skin and eyes) Fatigue or weakness Swelling in the extremities Increased heart rate Low oxygen levels leading to cyanosis (bluish discoloration of skin)
Diagnostic & Treatment
Diagnosis Path: Diagnosing sickle-cell thalassemia beta zero with acute chest syndrome involves a combination of medical history review, physical examination, and laboratory tests. Key diagnostic steps include: - Blood tests showing abnormal hemoglobin (hemoglobin electrophoresis) - Complete blood count (CBC) revealing anemia and abnormal red cells - Chest X-ray to evaluate lung involvement - Pulse oximetry to measure oxygen saturation - Blood cultures if an infection is suspected - Additional genetic testing may be performed to confirm specific hemoglobin gene mutations
Treatment Protocols: Managing this condition requires prompt and comprehensive care, including: - Oxygen therapy to improve oxygenation - Pain management for chest pain and discomfort - Hydration to prevent sickling and reduce blood viscosity - Antibiotics if infection is present or suspected - Blood transfusions to reduce sickled cells and improve oxygen delivery - Medications such as hydroxyurea to decrease sickling episodes - Supportive care and monitoring for organ complications - Long-term management often involves regular follow-up with healthcare providers to prevent sickling crises and manage complications Specialized care teams, including hematologists and pulmonologists, play a vital role in treatment planning and ongoing management.
Clinical Advice & FAQs
Billing Guidance
Is D57.431 a billable ICD-10 code?
Yes, D57.431 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D57.431?
Clinical documentation must specify the nature of Sickle-cell thalassemia beta zero with acute chest syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference